Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

R. Rivera, Donna; Peters, Solange; A. Panagiotou, Orestis; P. Shah, Dimpy; M. Kuderer, Nicole; Hsu, Chih–Yuan; M. Rubinstein, Samuel; J. Lee, Brendan; K. Choueiri, Toni; Lopes, Gilberto; Grivas, Petros; Painter, Corrie; I. Rini, Brian; A. Thompson, Michael; Arcobello, Jonathan; Bakouny, Ziad; B. Doroshow, Deborah; Egan, Pamela; Farmakiotis, Dimitrios; A. Fecher, Leslie; R. Friese, Christopher; D. Galsky, Matthew; Goel, Sanjay; Gupta, Shilpa; R. Hálfdánarson, Þorvarður; Halmos, Balázs; E. Hawley, Jessica; Raza Khaki, Ali; A. Lemmon, Christopher; Mishra, Sanjay; J. Olszewski, Adam; A. Pennell, Nathan; Puc, Matthew; G. Revankar, Sanjay; Schapira, Lidia; Schmidt, Andrew; K. Schwartz, Gary; Shah, Sumit; Wu, Julie; Xie, Zhuoer; C. Yeh, Albert; Zhu, Huili; Shyr, Yu; H. Lyman, Gary; L. Warner, Jeremy

doi:10.1158/2159-8290.cd-20-0941

Public

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Published in Cancer Discovery • Jul 22, 2020

Authors:

Donna R. Rivera

Solange Peters

Orestis A. Panagiotou

Abstract

Abstract Among 2,186 U.S. adults with invasive cancer and laboratory-confirmed SARS-CoV-2 infection, we examined the association of COVID-19 treatments with 30-day all-cause mortality and factors associated with treatment. Logistic regression with multiple adjustments (e.g., comorbidities, cancer st...

Subject

Coronavirus disease 2019 (COVID-19)

2019-20 coronavirus outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!